about
Hexapeptides that interfere with HIV-1 fusion peptide activity in liposomes block GP41-mediated membrane fusion.Differing specificities and isotypes of anti-citrullinated peptide/protein antibodies in palindromic rheumatism and rheumatoid arthritisThe use of chimeric vimentin citrullinated peptides for the diagnosis of rheumatoid arthritis.Structural and functional roles of HIV-1 gp41 pretransmembrane sequence segmentation.Conjugation of cell-penetrating peptides with poly(lactic-co-glycolic acid)-polyethylene glycol nanoparticles improves ocular drug deliveryDefinition of an 18-mer Synthetic Peptide Derived from the GB virus C E1 Protein as a New HIV-1 Entry Inhibitor.Design of synthetic peptidic constructs for the vaccine development against viral infections.Synthetic peptides for the immunodiagnosis of human diseases.Contribution of the Tyr-1 in Plantaricin149a to disrupt phospholipid model membranesDiagnostic and prognostic value of antibodies against chimeric fibrin/filaggrin citrullinated synthetic peptides in rheumatoid arthritis.Comparative study of the diagnostic and prognostic value of antibodies against chimeric citrullinated synthetic peptides and CCP3/CCP3.1 assays.Study of the interaction of GB virus C/Hepatitis G virus fusion peptides belonging to the E2 protein with phospholipid Langmuir monolayers.Effect of synthetic peptides belonging to E2 envelope protein of GB virus C on human immunodeficiency virus type 1 infection.PENETRATION OF POLYMERIC NANOPARTICLES LOADED WITH AN HIV-1 INHIBITOR PEPTIDE DERIVED FROM GB VIRUS C IN A VAGINAL MUCOSA MODEL.Roles of a conserved proline in the internal fusion peptide of Ebola glycoprotein.Lipid raft-like liposomes used for targeted delivery of a chimeric entry-inhibitor peptide with anti-HIV-1 activity.Calcium-dependent conformational changes of membrane-bound Ebola fusion peptide drive vesicle fusion.Pre-transmembrane sequence of Ebola glycoprotein. Interfacial hydrophobicity distribution and interaction with membranes.A cyclic GB virus C derived peptide with anti-HIV-1 activity targets the fusion peptide of HIV-1.Surface behavior of peptides from E1 GBV-C protein: Interaction with anionic model membranes and importance in HIV-1 FP inhibition.Antibodies against β-fibrin synthetic peptides: a study of their association with the immunogenetic background and disease course of rheumatoid arthritis patients.Study of the inhibition capacity of an 18-mer peptide domain of GBV-C virus on gp41-FP HIV-1 activity.Synthetic peptides of hepatitis G virus (GBV-C/HGV) in the selection of putative peptide inhibitors of the HIV-1 fusion peptide.Design and application of GB virus C (GBV-C) peptide microarrays for diagnosis of GBV-C/HIV-1 co-infection.Assessment of synthetic chimeric multiple antigenic peptides for diagnosis of GB virus C infection.Characterization of a putative fusogenic sequence in the E2 hepatitis G virus protein.Diagnostic value of anti-GBV-C antibodies in HIV-infected patients.Liposome destabilization induced by synthetic lipopeptides corresponding to envelope and non-structural domains of GBV-C/HGV virus. Conformational requirements for leakage.Application of a chimeric synthetic peptide in the development of a serologic method for the diagnosis of hepatitis G virus infection.Lipophilic derivatization of synthetic peptides belonging to NS3 and E2 proteins of GB virus-C (hepatitis G virus) and its effect on the interaction with model lipid membranes.Effects of sphingomyelin on melittin pore formation.Analysis of HIV-1 fusion peptide inhibition by synthetic peptides from E1 protein of GB virus C.The covalent coupling of HAV-VP3 (110-121) synthetic peptide to liposomes: physicochemical studies.Clay-vesicle interactions: fluorescence measurements and structural implications for slow release formulations of herbicides.Interaction of E2 and NS3 synthetic peptides of GB virus C/hepatitis G virus with model lipid membranes.Interaction of synthetic peptides corresponding to hepatitis G virus (HGV/GBV-C) E2 structural protein with phospholipid vesicles.Use of linear and multiple antigenic peptides in the immunodiagnosis of acute hepatitis A virus infection.Membrane-transferring sequences of the HIV-1 Gp41 ectodomain assemble into an immunogenic complex.Carbon nanotube composite peptide-based biosensors as putative diagnostic tools for rheumatoid arthritisAnti-citrullinated peptide antibodies in the serum of heavy smokers without rheumatoid arthritis. A differential effect of chronic obstructive pulmonary disease?
P50
Q33241568-3152D507-7674-4F53-9D76-BAAA01C8AD6AQ33805043-2A21D6E5-D8D2-410B-99F2-AA2CC57F3C65Q34043771-945FDFAE-EAF9-4C04-89F8-D85CF8699E1BQ34183957-B2CAE1A0-77A9-48ED-B2E5-DE156A1A47BAQ35043797-B5B3DB5F-0666-4119-BA38-8EC8B91A019CQ35932316-47C2D8E6-8934-487D-8FBE-A7B21DEB4C63Q35974145-7EE8AA88-3B62-4006-91FF-2BC1CE2E20ADQ36754516-8027BE70-E9F7-451C-9E67-AC3597AE6989Q37007318-675F8137-598B-45ED-A0AB-264B69543762Q37453967-661D96D7-E1CD-478C-B093-797396D48592Q38603829-6A8473A5-F195-4024-B85C-759FB28B1AFFQ38677770-78F945BB-8F3F-4102-B5C1-A5DC5E3E53A2Q39666265-856659F8-DCD8-4655-B66B-E384AA798BCEQ40069971-3CB79447-5835-4EB8-9DD2-DCC58EA6927CQ40530866-F9BFE58D-2CAA-4B24-96E2-159AF80C2C6EQ40561802-F01EB591-02A7-4ED4-A391-58AB426742E3Q40566335-0F69E196-58BB-438A-A538-00CA1EB17903Q40568440-385F86A6-2B96-4272-8225-79BC413ADD61Q41740298-2C78B100-20C2-4CE1-B6BD-1DB0AFAFF311Q42178285-CFDC6AF2-B274-4699-A973-7BDFF8655658Q42689017-0DF92007-988D-4CB5-8105-C7257EAFDAE9Q42747358-89AB6138-1C7E-48CA-A341-27082E19F1ACQ42987190-8F785F5C-C3B3-4EA2-A565-263B874020A1Q42987192-8F730DA0-7D9A-4808-95D2-4024FF03E038Q42990920-A800D440-49F8-48DE-9DC6-F49140479CFBQ42995201-AAB46EBC-2239-4B7E-8DB0-66A1CEC92048Q43036978-0DA203BC-CBEB-436C-B81D-EF385D1DECE7Q43041936-605B4D98-DC0C-4C6F-9E15-574B1720053DQ43042440-A2856072-895C-4C6E-A8E1-E0F2843F5540Q43048545-C0E23F13-F16E-417B-BE61-46884BAF05F2Q44428950-A39248F7-5929-4D70-A6BA-E354C06767A1Q44545056-480A367B-7A72-4606-94A5-9A0C7DE03ECDQ44708598-931AF42E-FB4D-42C1-9016-5A369FFB66BFQ44993516-C585FCD5-E323-4AA7-9769-9054A5B74BFDQ45389060-2DBB925A-B1F6-4B83-8369-974917F119FAQ45467900-22B43501-7424-47F5-8AA8-0313D9586983Q45744538-34A33AB3-B2AB-42EC-AA93-DD31E0484C10Q51806284-FF17EF3A-2F76-4BFA-998A-E3068F337F9DQ61700233-D451F2F7-890C-4823-99A9-4A0A0FD76FA9Q61958824-222270D1-2580-40C5-817D-08C73D2623F0
P50
description
hulumtuese
@sq
researcher
@en
wetenschapper
@nl
հետազոտող
@hy
name
María J. Gómara
@ast
María J. Gómara
@en
María J. Gómara
@es
María J. Gómara
@nl
María J. Gómara
@sl
type
label
María J. Gómara
@ast
María J. Gómara
@en
María J. Gómara
@es
María J. Gómara
@nl
María J. Gómara
@sl
prefLabel
María J. Gómara
@ast
María J. Gómara
@en
María J. Gómara
@es
María J. Gómara
@nl
María J. Gómara
@sl
P1053
F-2614-2015
P106
P1153
6602476851
P21
P31
P3829
P496
0000-0002-6906-4833